文献库 文献相关信息

题目:
Cancer treatment and survivorship statistics, 2012.
作者:
Siegel(Rebecca),DeSantis(Carol),Virgo(Katherine),Stein(Kevin),Mariotto(Angela),Smith(Tenbroeck),Cooper(Dexter),Gansler(Ted),Lerro(Catherine),Fedewa(Stacey),Lin(Chunchieh),Leach(Corinne),Cannady(Rachel Spillers),Cho(Hyunsoon),Scoppa(Steve),Hachey(Mark),Kirch(Rebecca),Jemal(Ahmedin),Ward(Elizabeth)
状态:
发布时间2012-07-10 , 更新时间 2012-11-20
期刊:
CA Cancer J Clin
摘要:
Although there has been considerable progress in reducing cancer incidence in the United States, the number of cancer survivors continues to increase due to the aging and growth of the population and improvements in survival rates. As a result, it is increasingly important to understand the unique medical and psychosocial needs of survivors and be aware of resources that can assist patients, caregivers, and health care providers in navigating the various phases of cancer survivorship. To highlight the challenges and opportunities to serve these survivors, the American Cancer Society and the National Cancer Institute estimated the prevalence of cancer survivors on January 1, 2012 and January 1, 2022, by cancer site. Data from Surveillance, Epidemiology, and End Results (SEER) registries were used to describe median age and stage at diagnosis and survival; data from the National Cancer Data Base and the SEER-Medicare Database were used to describe patterns of cancer treatment. An estimated 13.7 million Americans with a history of cancer were alive on January 1, 2012, and by January 1, 2022, that number will increase to nearly 18 million. The 3 most prevalent cancers among males are prostate (43%), colorectal (9%), and melanoma of the skin (7%), and those among females are breast (41%), uterine corpus (8%), and colorectal (8%). This article summarizes common cancer treatments, survival rates, and posttreatment concerns and introduces the new National Cancer Survivorship Resource Center, which has engaged more than 100 volunteer survivorship experts nationwide to develop tools for cancer survivors, caregivers, health care professionals, advocates, and policy makers.
语言:
eng
DOI:
10.3322/caac.21149

联系方式

山东省济南市章丘区文博路2号 齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号大学科技园北区F座4单元2楼

电话: 0531-88819269

E-mail: product@genelibs.com

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。